A review and revisit of nanoparticles for antimicrobial drug delivery

J Med Life. 2022 Mar;15(3):328-335. doi: 10.25122/jml-2021-0097.

Abstract

Antimicrobials are widely used to treat bacteria, viruses, fungi, and protozoa. Therefore, research and development of newer types of antimicrobials are important. Antimicrobial resistance has emerged as a major challenge to the healthcare system, although various alternative antimicrobials have been proposed. However, none of these show consistent and comparable efficacy to antimicrobials in clinical trials. More recently, nanoparticles have emerged as a potential solution to antimicrobial agents to overcome antimicrobial resistance. This article revisits and updates applications of various types of nanoparticles for the delivery of antimicrobial agents and their characterization. Though nanoparticle technology has some limitations, it provides an innovative approach to pharmaceutical technology. Furthermore, nanoparticles offer a variety of advantages, such as enhancement of solubility and permeation, leading to better efficacy. In this article, approaches commonly employed to improve antimicrobial therapy are discussed. These approaches have advantages and applications and provide a broader opportunity for pharmaceutical scientists to choose the proper method per the desired outcome.

Keywords: anti-infective agents; antibiotic, safety; nanomedicine; nanoparticle.

Publication types

  • Review

MeSH terms

  • Anti-Bacterial Agents
  • Anti-Infective Agents* / therapeutic use
  • Bacteria
  • Drug Delivery Systems
  • Humans
  • Nanoparticles*

Substances

  • Anti-Bacterial Agents
  • Anti-Infective Agents